Skip to main content
. 2018 Mar 6;2018:6853617. doi: 10.1155/2018/6853617

Table 2.

Prevalence of TN and US characteristics (%) according to the status of metabolic diseases.

Men Women
TN Microcalcification Taller-than-wide shape TN Microcalcification Taller-than-wide shape
Met-S 48.2 2.3 1.5 67.6 1.0 3.3
Without Met-S 39.6 1.0 1.9 52.3 0.9 2.1
P value <0.001 0.073 0.596 <0.001 0.731 0.102
Obesity 46.9 1.1 2.8 66.0 0.8 4.1
Without obesity 40.2 1.4 1.8 55.0 1.0 2.2
P value 0.001 0.646 0.222 <0.001 0.696 0.007
Central obesity 47.1 1.6 2.5 65.0 1.2 3.4
Without central obesity 39.0 1.2 1.6 50.2 0.7 1.6
P value <0.001 0.498 0.207 <0.001 0.210 0.003
Diabetes 50.3 0.8 1.6 69.5 1.5 3.9
Without diabetes 39.7 1.5 2.1 54.7 0.9 2.2
P value <0.001 0.371 0.550 <0.001 0.318 0.086
Hyperlipidaemia 45.3 1.7 2.5 64.7 1.2 2.5
Without hyperlipidaemia 38.3 1.0 1.6 52.5 0.9 2.5
P value <0.001 0.276 0.168 <0.001 0.361 0.733
Hypertension 45.8 1.3 1.9 66.1 1.3 2.6
Without hypertension 36.3 1.4 2.3 49.6 0.8 2.4
P value <0.001 0.806 0.576 <0.001 0.168 0.572
NAFLD 44.8 1.3 2.0 63.5 1.5 3.8
Without NAFLD 38.3 1.0 2.3 54.0 0.8 2.0
P value <0.001 0.650 0.699 <0.001 0.084 0.008

Met-S: metabolic syndrome; NAFLD: nonalcoholic fatty liver disease.